NCT01608373

Brief Summary

This prospective randomized study aims to comparison the effectiveness of intravenous lidocaine injection and intraperitoneam lidocaine irrigation on the relief of pain in patients undergoing laparoscopic cholecystectomy. A total of 83 patients will be randomized into one of three groups (group C or group I or group P) based on Excel number generation. Patients in group C will receive normal saline intravenous injection, and patients in group I will receive an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr. Patients in group P will receive intraperitoneal lidocaine irrigation with 3.5 mg/kg lidocaine and normal saline 100cc. Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 2, 4, 8, 12, 24, 48 hours postoperatively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
83

participants targeted

Target at P50-P75 for phase_4 postoperative-pain

Timeline
Completed

Started Jul 2011

Longer than P75 for phase_4 postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 31, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 2, 2013

Status Verified

July 1, 2011

Enrollment Period

3 years

First QC Date

May 26, 2012

Last Update Submit

August 1, 2013

Conditions

Keywords

PainLidocaineIntravenousIntraperitoneumLaparoscopic cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain measuring using Visual analogue scale at postoperative 2hour

    Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 2hour.

    Post op 2 hour

Secondary Outcomes (17)

  • Visual analogue scale 4hour

    Post op 4 hour

  • Visual analogue scale 8hour

    Post op 8 hour

  • Visual analogue scale 12 hour

    Post op 12hour

  • visual analogue scale 24hour

    Post op 24hour

  • Visual analogue scale 48 hour

    Post op 48hour

  • +12 more secondary outcomes

Study Arms (3)

Intravenous lidocaine injection group

ACTIVE COMPARATOR

Patients in Group I (intravenous lidocaine injection group) received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr.

Drug: Intravenous lidocaine injection

Intraperitoneal lidocaine irrigation group

ACTIVE COMPARATOR

Patients in Group P(intraperitoneal lidocaine irrigation group) receive a peritoneal lidocaine irrigation with 3.5mg/kg lidocaine and normal saline 100cc.

Drug: Intraperitoneal lidocaine irrigation group

Intravenous normal saline group

PLACEBO COMPARATOR

The patients in Group C (placebo control group) received normal saline intravenous injection

Drug: Intravenous normal saline injection

Interventions

Patients in Group I (intravenous lidocaine injection group) received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg/hr

Also known as: IV lidocaine
Intravenous lidocaine injection group

Patients in Group P(intraperitoneal lidocaine irrigation group) receive a peritoneal lidocaine irrigation with 3.5mg/kg lidocaine and normal saline 100cc. 50cc of irrigation fluid will be spread below diaphragm and 50cc of irrigation fluid will be spread around the gall bladder.

Also known as: IP lidocaine
Intraperitoneal lidocaine irrigation group

The patients in Group C (placebo control group) received normal saline intravenous injection

Also known as: IV normal saline
Intravenous normal saline group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Laparoscopic cholecystectomy

You may not qualify if:

  • mental change
  • allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hyun Kang

Seoul, South Korea

RECRUITING

Related Publications (1)

  • Yang SY, Kang H, Choi GJ, Shin HY, Baek CW, Jung YH, Choi YS. Efficacy of intraperitoneal and intravenous lidocaine on pain relief after laparoscopic cholecystectomy. J Int Med Res. 2014 Apr;42(2):307-19. doi: 10.1177/0300060513505493.

MeSH Terms

Conditions

Pain, PostoperativePain

Interventions

LidocaineSaline Solution

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Hyun Kang, Ph.D

    Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    STUDY CHAIR
  • Eun Jin Ahn

    Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hyun Kang, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

May 26, 2012

First Posted

May 31, 2012

Study Start

July 1, 2011

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

August 2, 2013

Record last verified: 2011-07

Locations